Prezzo di chiusura
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
86,8 TWD | -0,12% |
|
-2,80% | +5,85% |
Attività
Vendite per attività
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Monoclonal Antibodies
100,0
%
| 563 | 100,0 % | 492 | 100,0 % | -12,65% |
Vendite per regione
TWD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Taiwan
100,0
%
| 563 | 100,0 % | 492 | 100,0 % | -12,65% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chin-Ming Chang
CEO | Chief Executive Officer | - | - |
I Cheng Chen
DFI | Director of Finance/CFO | - | 01/06/08 |
Nien Yuan Chang
CHM | Chairman | - | 12/06/09 |
YingAn Lai
LAW | General Counsel | - | - |
Jason Mao
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Chi-Chuan Chen
BRD | Director/Board Member | 66 | - |
Ta Meng Tseng
BRD | Director/Board Member | 66 | 07/09/18 |
Nien Yuan Chang
CHM | Chairman | - | 12/06/09 |
Howard Lee
BRD | Director/Board Member | 62 | 26/05/17 |
Tien Chieh Li
BRD | Director/Board Member | - | 24/02/21 |
Shih Chia Lin
BRD | Director/Board Member | - | - |
Gwo-Fong Lin
BRD | Director/Board Member | 68 | 04/06/20 |
Chin Ting Chiu
BRD | Director/Board Member | - | - |
Hui Chuan Chang
BRD | Director/Board Member | - | - |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 273 078 525 | 181 990 525 ( 66,64 %) | 0 | 66,64 % |
Coordinate società
![Indirizzo TaiMed Biologics Inc.(4147)](https://cdn.zonebourse.com/static/address/20706000.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+5,85% | 730 Mln | |
+16,91% | 122 Mrd | |
+18,57% | 112 Mrd | |
-23,26% | 19,33 Mrd | |
-18,14% | 16,17 Mrd | |
-20,35% | 15,6 Mrd | |
-47,75% | 14,65 Mrd | |
+56,97% | 14,34 Mrd | |
+6,41% | 14 Mrd | |
+122,52% | 11,29 Mrd |
- Borsa valori
- Azioni
- Azione 4147
- Società TaiMed Biologics Inc.